Readers hoping to buy Cohen & Steers, Inc. ( NYSE:CNS ) for its dividend will need to make their move shortly, as the... Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under ...

If we miss even one of these pillars, we will not be able to achieve TB elimination," added Dr Burhan. And we have to find, treat and prevent TB in a people-centred, rights-based and gender ...

Segment featuring members of the CNS management team and leading Neuro-Oncologist and Key Opinion Leader, Dr. Samuel Goldlust Access the segment here HOUSTON, TX / ACCESSWIRE / October 10 ...

Minoryx Therapeutics, a late-stage biotech company focused on the development of therapies for orphan central nervous system (CNS) disorders and Neuraxpharm Group (Neuraxpharm), a leading European ...

Jude Law was joined by two of his oldest children as he was honored with the unveiling of his star on the Hollywood Walk of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The global CNS Treatment and Therapy Market is poised for substantial growth, with a projected valuation of USD 123.2 billion by the end of 2023. This market is expected to further expand at a CAGR of ...

Background: Matrix metalloproteinases (MMPs) are thought to mediate cellular infiltration in central nervous system (CNS) inflammation by cleaving extracellular matrix proteins associated with the ...

Dr. med. from Universitatsspital Zurich ... live video webcast via the Events page on the Investors section of the CNS Pharmaceuticals website, with a replay available two hours after the live ...